drugset / Trial / NCT06833125

The Prophylactic Effect of Garlic Tablets to Prevent Nosocomial Infections in Intensive Care Unit Patients.

NCT06833125 ↗

Phase 3 Enrolling by invitation 62 enrolled Alexandria University
RandomizedParallel-groupOpen-labelPrevention

Summary

The goal of this clinical trial is to learn if garlic tablets works to prevent nosocomial infections in hospitalized patients in ICU. The main questions it aims to answer are: Does garlic tablets administration lower the occurence of nosocomial infections in hospitalized patients in ICU?

Timeline

Start
2025-03-01
Primary completion
2026-03-01
Completion
2026-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Garlic powder standardized to allicin Unknown 300 mg —

Indications